RT @ALSMNDAlliance: @ALSTDI Read now: encouraging results from phase 2/3 clinical trial of #Masitinib in people with #ALS #MND https://t.co…
Senior Director of Marketing, Communications + PR
Give today to ALS research. Your donation helps advance our most promising treatment,
AT-1501, and other potential treatments!